Abstract:
Although with low mortality rates, neglected diseases are causing severe and permanent disabilities and deformities affecting approximately 1 billion people in the world, yielding millions of Disability Adjusted Life Years. Unfortunately, despite scientific and technological advances realized during the last century and the evidence of possible research output in the biomedical field, a large population living in developing countries, do not have access to adequate affordable treatment against infectious diseases. The reasons why the so-called neglected diseases have been given very little attention are local, national and international. First of all, these diseases affect almost exclusively extremely poor populations living in remote areas beyond the reach of health services. Secondly, they occur in developing countries where few governments are putting science, technology, and innovation at the centre of their strategies and, in the meantime, war and conflicts are financed at the expense of health services. Thirdly, little (or no) research is currently dedicated to the most neglected diseases because they offer negligible marketable and profitable issues, getting less than 10% of the global spending on health research in spite of being among diseases or conditions that account for 90% of the global disease burden. New initiatives are needed and coordination for a better efficiency should strengthen the existing projects such as Drug for Neglected Diseases Initiative, Global Alliance for Vaccines and Immunization, The Human Hookworm Vaccine initiative and the Foundation for Innovative New Diagnostics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AIDS:
-
acquired immune defense system
- DALY:
-
disability adjusted life years
- DF:
-
dengue fever
- DHF:
-
dengue hemorrhagic fever
- DNDi:
-
drug for neglected diseases initiative
- DSS:
-
dengue shock syndrome
- EU:
-
European union
- FIND:
-
foundation for innovative new diagnostics
- FL:
-
filariasis lymphatic
- GAVI:
-
global alliance for vaccines and immunization
- HHVI:
-
human hookworm vaccine initiative
- HIV:
-
human immunodeficiency virus
- MDG:
-
millennium development goals
- ND:
-
neglected disease
- OCDE:
-
organization for economic cooperation and development
- OCP:
- UNDP:
-
United Nations Development Program
- USAID:
-
United States Agency for Development
- VL:
-
visceral leishmaniasis
- WHO:
-
World Health Organization
- YLD:
-
years lived with disability
- YLL:
-
years of life lost
References
Bartram J, Lewis K, Lenton R, Wright A. (2005). Lancet. 365: 810–812.
Boutayeb A. (2006). Trans R Soc Trop Med Hyg. 100: 191–199.
Boutayeb A. (2007). Developing countries and neglected diseases: Challenges and perspectives. Int J Equity Health. doi: 10.1186/1475–9276–6–20.
Derouich M, Boutayeb A. (2006). Appl Math Comput. 177: 528–544.
European Parliament (EP). (2005). Report on Major and Neglected Diseases in Developing Countries. http://www.europarl.europa.eu. Cited 20 Jan 2008.
Franco-Paredes C, Jones D, Rodrigues-Morales AJ, Santos-Preciado JI. (2007). BMC Public Health. 7: 11.
Holveck JC, Ehrenberg JP, Ault SK, Rojas R, Vasquez J, Cerquiera MT, Ippolito-Shepherd J, Genovese MA, Periago MR. (2007). BMC Public Health. 7: 6.
Mashelkar RA. (2005). Innov Strat Today. 1: 16–32.
Mathers CD, Ezzati M, Lopez AD. (2007). PLOS Negl Trop Dis. 1: e114.
Mèdecins Sans Frontières (MSF). (2007). Report on Drugs for Neglected Diseases. [http://www.accessmed-msf.org/dnd/dndi.asp]. Accessed June 18, 2007.
Molyneux DH. (2004). Lancet. 364: 380–383.
Molyneux DH, Hotez PJ, Fenwick A. (2005). PLOS Med. 2: e336.
Morel CM. (2003). EMBO Rep. 4: S35–S38.
Morel C, Broun D, Dangi A, Elias C, Gardener C, Gupta RK, Haycock J, Heher T, Hoetz P, Kettler H, Keusch G, Krattiger A, Kreutz F, Lee K, Mahoney R, Mashelkar RA, Min H, Matlin S, Mzimba M, Oehler J, Ridley R, Senanayake P, Thorsteinsdottir H, Singer PA, Yun M. (2005). Innov Strat Today. 1: 1–15.
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. (2007). Lancet. 307: 851–858.
Perera M, Witehead M, Molyneux D, Weerasooriya M, Gunatilleke G. (2007). PLOS Negl Trop Dis. 1: e128.
Saxena S, Thornicroft G, Whiteford H. (2007). Lancet. 370: 878–889.
Thornicroft G. (2007). Lancet. 370: 807–808.
Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. (2002). Lancet. 359: 2188–2194.
World Health Organization. (2003a). Global Defence Against the Infectious Diseases Threat. World Health Organization, Geneva.
WHO. (2002). World Health Organization Annual Report. http://www.who.int/whr/2002/en. Cited 20 Dec 2007.
WHO. (2003b). World Health Organization annual Report. http://www.who.int/whr/2003/en. Cited 20 Jan 2008.
WHO. (2004). World Health Organization annual Report. http://www.who.int/whr/2004/en. Cited 20 Jan 2008.
Acknowledgments
This work is partially funded by the Program Global de Recherche of the university Mohamed Ier.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Boutayeb, A. (2010). The Burden of Neglected Diseases in Developing Countries. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_31
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_31
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine